Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life?
-
Published:2024-05-31
Issue:
Volume:
Page:
-
ISSN:0043-5325
-
Container-title:Wiener klinische Wochenschrift
-
language:en
-
Short-container-title:Wien Klin Wochenschr
Author:
Hirschmann DorianORCID, Nasiri DanialORCID, Entenmann Christian JoachimORCID, Haberler ChristineORCID, Roetzer ThomasORCID, Dorfer ChristianORCID, Millesi MatthiasORCID
Abstract
Summary
Objective
To identify factors for tumor relapse and poor outcome in patients with meningiomas in the first two decades of life.
Methods
All patients ≤ 21 years of age who underwent resection of a meningioma at the department of neurosurgery, Medical University of Vienna between 1989 and 2022 were included in this retrospective study. Clinical and radiological data were extracted from the medical records. Outcome and tumor relapse were analyzed for tumor location, histological findings and extent of resection.
Results
In this study 18 patients were included, 6 meningiomas were located in the skull base, 5 in the convexity and 7 in other locations including intraventricular and spine (2 patients each), falx, intraparenchymal and optic nerve sheath. Most frequent symptoms were seizures and cranial nerve palsy. In total 56% of the meningiomas were World Health organization (WHO) grade 1, 39% grade 2 and 5% grade 3. Gross total resection was achieved in 67%. The overall relapse rate was 61% and 50% underwent repeat surgery. All patients with convexity meningiomas became seizure free and had a favorable outcome. Relapse and clinical outcome were independent of WHO grade among the whole cohort but the outcome significantly depended on the WHO grade when patients with skull base meningiomas were analyzed as a subgroup. The relapse rate was significantly higher in cases of skull base location (100% vs. 42%, p = 0.038) and after subtotal resection (100% vs. 42%, p = 0.038). Clinical outcome was also significantly worse and the rate of complications was higher in patients with skull base meningiomas.
Conclusion
Patients with convexity meningiomas in the first two decades of life have a good outcome due to high chance of gross total resection. Patients with skull base meningioma are at high risk of relapse and poor outcome, particularly those with WHO grades 2 and 3. Subtotal resection in patients with skull base location is probably the main reason for this difference.
Funder
Medical University of Vienna
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Amirjamshidi A, Mehrazin M, Abbassioun K (2000) Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 16:406–416. https://doi.org/10.1007/s003819900205 2. Burkhardt JK, Neidert MC, Grotzer MA, Krayenbühl N, Bozinov O (2013) Surgical resection of pediatric skull base meningiomas. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 29:83–87. https://doi.org/10.1007/s00381-012-1906-6 3. Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Avşar T, Li J, Murray PB, Henegariu O, Yilmaz S, Günel JM, Carrión-Grant G, Yilmaz B, Grady C, Tanrikulu B, Bakircioğlu M, Kaymakçalan H, Caglayan AO, Sencar L, Ceyhun E, Atik AF, Bayri Y, Bai H, Kolb LE, Hebert RM, Omay SB, Mishra-Gorur K, Choi M, Overton JD, Holland EC, Mane S, State MW, Bilgüvar K, Baehring JM, Gutin PH, Piepmeier JM, Vortmeyer A, Brennan CW, Pamir MN, Kiliç T, Lifton RP, Noonan JP, Yasuno K, Günel M (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science (New York, NY) 339:1077–1080. https://doi.org/10.1126/science.1233009 4. Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, Aizer AA, Alexander BM, Ligon KL, Reardon DA, Wen PY, Al-Mefty O, Ligon AH, Dubuc AM, Beroukhim R, Claus EB, Dunn IF, Santagata S, Bi WL. A molecularly integrated grade for meningioma. Neuro-Oncology. 2022;24:796–808. https://doi.org/10.1093/neuonc/noab213. 5. Greene S, Nair N, Ojemann JG, Ellenbogen RG, Avellino AM. Meningiomas in children. Pediatr Neurosurg. 2008;44:9–13. https://doi.org/10.1159/000110656.
|
|